nodes	percent_of_prediction	percent_of_DWPC	metapath
Neostigmine—BCHE—Ramipril—type 2 diabetes mellitus	0.229	0.358	CbGbCtD
Neostigmine—ABCB1—Linagliptin—type 2 diabetes mellitus	0.113	0.178	CbGbCtD
Neostigmine—ABCB1—Sitagliptin—type 2 diabetes mellitus	0.101	0.158	CbGbCtD
Neostigmine—ABCB1—Chlorpropamide—type 2 diabetes mellitus	0.0731	0.115	CbGbCtD
Neostigmine—ABCB1—Bromocriptine—type 2 diabetes mellitus	0.0502	0.0787	CbGbCtD
Neostigmine—ABCB1—Glyburide—type 2 diabetes mellitus	0.0374	0.0586	CbGbCtD
Neostigmine—ABCB1—Losartan—type 2 diabetes mellitus	0.0342	0.0536	CbGbCtD
Neostigmine—Pyridostigmine—CYP3A4—type 2 diabetes mellitus	0.00151	0.569	CrCbGaD
Neostigmine—Rivastigmine—CYP3A4—type 2 diabetes mellitus	0.00114	0.431	CrCbGaD
Neostigmine—Loss of consciousness—Valsartan—type 2 diabetes mellitus	0.000407	0.00158	CcSEcCtD
Neostigmine—Muscle spasms—Metformin—type 2 diabetes mellitus	0.000405	0.00158	CcSEcCtD
Neostigmine—Nausea—Rosiglitazone—type 2 diabetes mellitus	0.000403	0.00157	CcSEcCtD
Neostigmine—Nervous system disorder—Gliclazide—type 2 diabetes mellitus	0.000403	0.00157	CcSEcCtD
Neostigmine—Tachycardia—Gliclazide—type 2 diabetes mellitus	0.000401	0.00156	CcSEcCtD
Neostigmine—Skin disorder—Gliclazide—type 2 diabetes mellitus	0.000399	0.00155	CcSEcCtD
Neostigmine—Flushing—Losartan—type 2 diabetes mellitus	0.000399	0.00155	CcSEcCtD
Neostigmine—Asthenia—Glimepiride—type 2 diabetes mellitus	0.000398	0.00155	CcSEcCtD
Neostigmine—Urticaria—Bromocriptine—type 2 diabetes mellitus	0.000398	0.00155	CcSEcCtD
Neostigmine—Hyperhidrosis—Gliclazide—type 2 diabetes mellitus	0.000397	0.00155	CcSEcCtD
Neostigmine—Asthenia—Sitagliptin—type 2 diabetes mellitus	0.000397	0.00154	CcSEcCtD
Neostigmine—Convulsion—Orlistat—type 2 diabetes mellitus	0.000396	0.00154	CcSEcCtD
Neostigmine—Abdominal pain—Bromocriptine—type 2 diabetes mellitus	0.000396	0.00154	CcSEcCtD
Neostigmine—Gastrointestinal disorder—Glyburide—type 2 diabetes mellitus	0.000395	0.00154	CcSEcCtD
Neostigmine—Arthralgia—Valsartan—type 2 diabetes mellitus	0.000394	0.00153	CcSEcCtD
Neostigmine—Dizziness—Glipizide—type 2 diabetes mellitus	0.000393	0.00153	CcSEcCtD
Neostigmine—Pruritus—Glimepiride—type 2 diabetes mellitus	0.000393	0.00153	CcSEcCtD
Neostigmine—Flatulence—Irbesartan—type 2 diabetes mellitus	0.000392	0.00152	CcSEcCtD
Neostigmine—Unspecified disorder of skin and subcutaneous tissue—Valsartan—type 2 diabetes mellitus	0.000391	0.00152	CcSEcCtD
Neostigmine—Diarrhoea—Pioglitazone—type 2 diabetes mellitus	0.00039	0.00152	CcSEcCtD
Neostigmine—Unspecified disorder of skin and subcutaneous tissue—Orlistat—type 2 diabetes mellitus	0.000386	0.0015	CcSEcCtD
Neostigmine—Dry mouth—Valsartan—type 2 diabetes mellitus	0.000385	0.0015	CcSEcCtD
Neostigmine—Hypotension—Gliclazide—type 2 diabetes mellitus	0.000384	0.00149	CcSEcCtD
Neostigmine—Arrhythmia—Losartan—type 2 diabetes mellitus	0.000384	0.00149	CcSEcCtD
Neostigmine—Muscle spasms—Irbesartan—type 2 diabetes mellitus	0.000382	0.00149	CcSEcCtD
Neostigmine—Dry mouth—Orlistat—type 2 diabetes mellitus	0.000381	0.00148	CcSEcCtD
Neostigmine—Diarrhoea—Glimepiride—type 2 diabetes mellitus	0.00038	0.00148	CcSEcCtD
Neostigmine—Diarrhoea—Sitagliptin—type 2 diabetes mellitus	0.000378	0.00147	CcSEcCtD
Neostigmine—Vomiting—Glipizide—type 2 diabetes mellitus	0.000378	0.00147	CcSEcCtD
Neostigmine—Syncope—Metformin—type 2 diabetes mellitus	0.000378	0.00147	CcSEcCtD
Neostigmine—Anaphylactic shock—Valsartan—type 2 diabetes mellitus	0.000377	0.00147	CcSEcCtD
Neostigmine—Dizziness—Pioglitazone—type 2 diabetes mellitus	0.000377	0.00147	CcSEcCtD
Neostigmine—Rash—Glipizide—type 2 diabetes mellitus	0.000375	0.00146	CcSEcCtD
Neostigmine—Dermatitis—Glipizide—type 2 diabetes mellitus	0.000375	0.00146	CcSEcCtD
Neostigmine—Musculoskeletal discomfort—Gliclazide—type 2 diabetes mellitus	0.000374	0.00146	CcSEcCtD
Neostigmine—Gastrointestinal pain—Glyburide—type 2 diabetes mellitus	0.000374	0.00146	CcSEcCtD
Neostigmine—Anaphylactic shock—Orlistat—type 2 diabetes mellitus	0.000373	0.00145	CcSEcCtD
Neostigmine—Headache—Glipizide—type 2 diabetes mellitus	0.000372	0.00145	CcSEcCtD
Neostigmine—Insomnia—Gliclazide—type 2 diabetes mellitus	0.000372	0.00145	CcSEcCtD
Neostigmine—Shock—Valsartan—type 2 diabetes mellitus	0.000371	0.00144	CcSEcCtD
Neostigmine—Loss of consciousness—Metformin—type 2 diabetes mellitus	0.00037	0.00144	CcSEcCtD
Neostigmine—Nervous system disorder—Valsartan—type 2 diabetes mellitus	0.00037	0.00144	CcSEcCtD
Neostigmine—Flatulence—Losartan—type 2 diabetes mellitus	0.000369	0.00143	CcSEcCtD
Neostigmine—Dizziness—Glimepiride—type 2 diabetes mellitus	0.000367	0.00143	CcSEcCtD
Neostigmine—Skin disorder—Valsartan—type 2 diabetes mellitus	0.000367	0.00143	CcSEcCtD
Neostigmine—Dyspnoea—Gliclazide—type 2 diabetes mellitus	0.000366	0.00142	CcSEcCtD
Neostigmine—Nervous system disorder—Orlistat—type 2 diabetes mellitus	0.000366	0.00142	CcSEcCtD
Neostigmine—Dizziness—Sitagliptin—type 2 diabetes mellitus	0.000366	0.00142	CcSEcCtD
Neostigmine—Agitation—Irbesartan—type 2 diabetes mellitus	0.000365	0.00142	CcSEcCtD
Neostigmine—Somnolence—Gliclazide—type 2 diabetes mellitus	0.000365	0.00142	CcSEcCtD
Neostigmine—Urticaria—Glyburide—type 2 diabetes mellitus	0.000363	0.00141	CcSEcCtD
Neostigmine—Skin disorder—Orlistat—type 2 diabetes mellitus	0.000362	0.00141	CcSEcCtD
Neostigmine—Connective tissue disorder—Ramipril—type 2 diabetes mellitus	0.000362	0.00141	CcSEcCtD
Neostigmine—Abdominal pain—Glyburide—type 2 diabetes mellitus	0.000362	0.00141	CcSEcCtD
Neostigmine—Hyperhidrosis—Orlistat—type 2 diabetes mellitus	0.000361	0.0014	CcSEcCtD
Neostigmine—Muscle spasms—Losartan—type 2 diabetes mellitus	0.00036	0.0014	CcSEcCtD
Neostigmine—Asthenia—Bromocriptine—type 2 diabetes mellitus	0.000359	0.0014	CcSEcCtD
Neostigmine—Headache—Pioglitazone—type 2 diabetes mellitus	0.000357	0.00139	CcSEcCtD
Neostigmine—Syncope—Irbesartan—type 2 diabetes mellitus	0.000356	0.00139	CcSEcCtD
Neostigmine—Unspecified disorder of skin and subcutaneous tissue—Metformin—type 2 diabetes mellitus	0.000356	0.00139	CcSEcCtD
Neostigmine—Gastrointestinal disorder—Gliclazide—type 2 diabetes mellitus	0.000355	0.00138	CcSEcCtD
Neostigmine—Nausea—Glipizide—type 2 diabetes mellitus	0.000353	0.00137	CcSEcCtD
Neostigmine—Vomiting—Glimepiride—type 2 diabetes mellitus	0.000353	0.00137	CcSEcCtD
Neostigmine—Hypotension—Valsartan—type 2 diabetes mellitus	0.000353	0.00137	CcSEcCtD
Neostigmine—Vomiting—Sitagliptin—type 2 diabetes mellitus	0.000352	0.00137	CcSEcCtD
Neostigmine—Rash—Glimepiride—type 2 diabetes mellitus	0.00035	0.00136	CcSEcCtD
Neostigmine—Dermatitis—Glimepiride—type 2 diabetes mellitus	0.000349	0.00136	CcSEcCtD
Neostigmine—Loss of consciousness—Irbesartan—type 2 diabetes mellitus	0.000349	0.00136	CcSEcCtD
Neostigmine—Rash—Sitagliptin—type 2 diabetes mellitus	0.000349	0.00136	CcSEcCtD
Neostigmine—Dermatitis—Sitagliptin—type 2 diabetes mellitus	0.000348	0.00136	CcSEcCtD
Neostigmine—Headache—Glimepiride—type 2 diabetes mellitus	0.000348	0.00135	CcSEcCtD
Neostigmine—Headache—Sitagliptin—type 2 diabetes mellitus	0.000346	0.00135	CcSEcCtD
Neostigmine—Musculoskeletal discomfort—Valsartan—type 2 diabetes mellitus	0.000344	0.00134	CcSEcCtD
Neostigmine—Agitation—Losartan—type 2 diabetes mellitus	0.000344	0.00134	CcSEcCtD
Neostigmine—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	0.000342	0.00133	CcSEcCtD
Neostigmine—Flushing—Ramipril—type 2 diabetes mellitus	0.000342	0.00133	CcSEcCtD
Neostigmine—Insomnia—Valsartan—type 2 diabetes mellitus	0.000341	0.00133	CcSEcCtD
Neostigmine—Musculoskeletal discomfort—Orlistat—type 2 diabetes mellitus	0.00034	0.00132	CcSEcCtD
Neostigmine—Arthralgia—Irbesartan—type 2 diabetes mellitus	0.000338	0.00132	CcSEcCtD
Neostigmine—Shock—Metformin—type 2 diabetes mellitus	0.000338	0.00132	CcSEcCtD
Neostigmine—Insomnia—Orlistat—type 2 diabetes mellitus	0.000337	0.00131	CcSEcCtD
Neostigmine—Hypersensitivity—Glyburide—type 2 diabetes mellitus	0.000337	0.00131	CcSEcCtD
Neostigmine—Nervous system disorder—Metformin—type 2 diabetes mellitus	0.000337	0.00131	CcSEcCtD
Neostigmine—Dyspnoea—Valsartan—type 2 diabetes mellitus	0.000337	0.00131	CcSEcCtD
Neostigmine—Unspecified disorder of skin and subcutaneous tissue—Irbesartan—type 2 diabetes mellitus	0.000336	0.00131	CcSEcCtD
Neostigmine—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	0.000336	0.00131	CcSEcCtD
Neostigmine—Somnolence—Valsartan—type 2 diabetes mellitus	0.000336	0.00131	CcSEcCtD
Neostigmine—Syncope—Losartan—type 2 diabetes mellitus	0.000335	0.0013	CcSEcCtD
Neostigmine—Skin disorder—Metformin—type 2 diabetes mellitus	0.000334	0.0013	CcSEcCtD
Neostigmine—Hyperhidrosis—Metformin—type 2 diabetes mellitus	0.000332	0.00129	CcSEcCtD
Neostigmine—Mediastinal disorder—Ramipril—type 2 diabetes mellitus	0.000332	0.00129	CcSEcCtD
Neostigmine—Dizziness—Bromocriptine—type 2 diabetes mellitus	0.000331	0.00129	CcSEcCtD
Neostigmine—Dry mouth—Irbesartan—type 2 diabetes mellitus	0.000331	0.00129	CcSEcCtD
Neostigmine—Nausea—Glimepiride—type 2 diabetes mellitus	0.00033	0.00128	CcSEcCtD
Neostigmine—Arrhythmia—Ramipril—type 2 diabetes mellitus	0.000329	0.00128	CcSEcCtD
Neostigmine—Loss of consciousness—Losartan—type 2 diabetes mellitus	0.000329	0.00128	CcSEcCtD
Neostigmine—Nausea—Sitagliptin—type 2 diabetes mellitus	0.000329	0.00128	CcSEcCtD
Neostigmine—Asthenia—Glyburide—type 2 diabetes mellitus	0.000328	0.00128	CcSEcCtD
Neostigmine—Urticaria—Gliclazide—type 2 diabetes mellitus	0.000326	0.00127	CcSEcCtD
Neostigmine—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	0.000326	0.00127	CcSEcCtD
Neostigmine—Abdominal pain—Gliclazide—type 2 diabetes mellitus	0.000325	0.00126	CcSEcCtD
Neostigmine—Anaphylactic shock—Irbesartan—type 2 diabetes mellitus	0.000324	0.00126	CcSEcCtD
Neostigmine—Pruritus—Glyburide—type 2 diabetes mellitus	0.000324	0.00126	CcSEcCtD
Neostigmine—Mental disorder—Ramipril—type 2 diabetes mellitus	0.000323	0.00126	CcSEcCtD
Neostigmine—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	0.000322	0.00125	CcSEcCtD
Neostigmine—Hypotension—Metformin—type 2 diabetes mellitus	0.000321	0.00125	CcSEcCtD
Neostigmine—Shock—Irbesartan—type 2 diabetes mellitus	0.000319	0.00124	CcSEcCtD
Neostigmine—Arthralgia—Losartan—type 2 diabetes mellitus	0.000318	0.00124	CcSEcCtD
Neostigmine—Vomiting—Bromocriptine—type 2 diabetes mellitus	0.000318	0.00124	CcSEcCtD
Neostigmine—Nervous system disorder—Irbesartan—type 2 diabetes mellitus	0.000318	0.00124	CcSEcCtD
Neostigmine—Tachycardia—Irbesartan—type 2 diabetes mellitus	0.000317	0.00123	CcSEcCtD
Neostigmine—Rash—Bromocriptine—type 2 diabetes mellitus	0.000316	0.00123	CcSEcCtD
Neostigmine—Dermatitis—Bromocriptine—type 2 diabetes mellitus	0.000315	0.00123	CcSEcCtD
Neostigmine—Skin disorder—Irbesartan—type 2 diabetes mellitus	0.000315	0.00123	CcSEcCtD
Neostigmine—Hyperhidrosis—Irbesartan—type 2 diabetes mellitus	0.000314	0.00122	CcSEcCtD
Neostigmine—Headache—Bromocriptine—type 2 diabetes mellitus	0.000314	0.00122	CcSEcCtD
Neostigmine—Musculoskeletal discomfort—Metformin—type 2 diabetes mellitus	0.000313	0.00122	CcSEcCtD
Neostigmine—Diarrhoea—Glyburide—type 2 diabetes mellitus	0.000313	0.00122	CcSEcCtD
Neostigmine—Dry mouth—Losartan—type 2 diabetes mellitus	0.000311	0.00121	CcSEcCtD
Neostigmine—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	0.000309	0.0012	CcSEcCtD
Neostigmine—Muscle spasms—Ramipril—type 2 diabetes mellitus	0.000308	0.0012	CcSEcCtD
Neostigmine—Dyspnoea—Metformin—type 2 diabetes mellitus	0.000306	0.00119	CcSEcCtD
Neostigmine—Somnolence—Metformin—type 2 diabetes mellitus	0.000306	0.00119	CcSEcCtD
Neostigmine—Anaphylactic shock—Losartan—type 2 diabetes mellitus	0.000305	0.00119	CcSEcCtD
Neostigmine—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	0.000305	0.00119	CcSEcCtD
Neostigmine—Hypotension—Irbesartan—type 2 diabetes mellitus	0.000303	0.00118	CcSEcCtD
Neostigmine—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	0.000303	0.00118	CcSEcCtD
Neostigmine—Shock—Losartan—type 2 diabetes mellitus	0.0003	0.00117	CcSEcCtD
Neostigmine—Urticaria—Valsartan—type 2 diabetes mellitus	0.0003	0.00117	CcSEcCtD
Neostigmine—Nervous system disorder—Losartan—type 2 diabetes mellitus	0.000299	0.00116	CcSEcCtD
Neostigmine—Abdominal pain—Valsartan—type 2 diabetes mellitus	0.000298	0.00116	CcSEcCtD
Neostigmine—Tachycardia—Losartan—type 2 diabetes mellitus	0.000298	0.00116	CcSEcCtD
Neostigmine—Nausea—Bromocriptine—type 2 diabetes mellitus	0.000297	0.00116	CcSEcCtD
Neostigmine—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	0.000297	0.00115	CcSEcCtD
Neostigmine—Urticaria—Orlistat—type 2 diabetes mellitus	0.000296	0.00115	CcSEcCtD
Neostigmine—Musculoskeletal discomfort—Irbesartan—type 2 diabetes mellitus	0.000296	0.00115	CcSEcCtD
Neostigmine—Hyperhidrosis—Losartan—type 2 diabetes mellitus	0.000295	0.00115	CcSEcCtD
Neostigmine—Abdominal pain—Orlistat—type 2 diabetes mellitus	0.000295	0.00115	CcSEcCtD
Neostigmine—Asthenia—Gliclazide—type 2 diabetes mellitus	0.000295	0.00115	CcSEcCtD
Neostigmine—Agitation—Ramipril—type 2 diabetes mellitus	0.000295	0.00115	CcSEcCtD
Neostigmine—Vomiting—Glyburide—type 2 diabetes mellitus	0.000291	0.00113	CcSEcCtD
Neostigmine—Pruritus—Gliclazide—type 2 diabetes mellitus	0.000291	0.00113	CcSEcCtD
Neostigmine—Dyspnoea—Irbesartan—type 2 diabetes mellitus	0.000289	0.00113	CcSEcCtD
Neostigmine—Rash—Glyburide—type 2 diabetes mellitus	0.000288	0.00112	CcSEcCtD
Neostigmine—Somnolence—Irbesartan—type 2 diabetes mellitus	0.000288	0.00112	CcSEcCtD
Neostigmine—Dermatitis—Glyburide—type 2 diabetes mellitus	0.000288	0.00112	CcSEcCtD
Neostigmine—Syncope—Ramipril—type 2 diabetes mellitus	0.000288	0.00112	CcSEcCtD
Neostigmine—Headache—Glyburide—type 2 diabetes mellitus	0.000287	0.00112	CcSEcCtD
Neostigmine—Hypotension—Losartan—type 2 diabetes mellitus	0.000285	0.00111	CcSEcCtD
Neostigmine—Loss of consciousness—Ramipril—type 2 diabetes mellitus	0.000282	0.0011	CcSEcCtD
Neostigmine—Diarrhoea—Gliclazide—type 2 diabetes mellitus	0.000281	0.00109	CcSEcCtD
Neostigmine—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	0.000281	0.00109	CcSEcCtD
Neostigmine—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	0.00028	0.00109	CcSEcCtD
Neostigmine—Musculoskeletal discomfort—Losartan—type 2 diabetes mellitus	0.000278	0.00108	CcSEcCtD
Neostigmine—Hypersensitivity—Valsartan—type 2 diabetes mellitus	0.000278	0.00108	CcSEcCtD
Neostigmine—Convulsion—Ramipril—type 2 diabetes mellitus	0.000278	0.00108	CcSEcCtD
Neostigmine—Insomnia—Losartan—type 2 diabetes mellitus	0.000276	0.00107	CcSEcCtD
Neostigmine—Hypersensitivity—Orlistat—type 2 diabetes mellitus	0.000275	0.00107	CcSEcCtD
Neostigmine—Urticaria—Metformin—type 2 diabetes mellitus	0.000273	0.00106	CcSEcCtD
Neostigmine—Arthralgia—Ramipril—type 2 diabetes mellitus	0.000273	0.00106	CcSEcCtD
Neostigmine—Dyspnoea—Losartan—type 2 diabetes mellitus	0.000272	0.00106	CcSEcCtD
Neostigmine—Nausea—Glyburide—type 2 diabetes mellitus	0.000272	0.00106	CcSEcCtD
Neostigmine—Abdominal pain—Metformin—type 2 diabetes mellitus	0.000272	0.00106	CcSEcCtD
Neostigmine—Dizziness—Gliclazide—type 2 diabetes mellitus	0.000272	0.00106	CcSEcCtD
Neostigmine—Somnolence—Losartan—type 2 diabetes mellitus	0.000271	0.00106	CcSEcCtD
Neostigmine—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 2 diabetes mellitus	0.000271	0.00105	CcSEcCtD
Neostigmine—Asthenia—Valsartan—type 2 diabetes mellitus	0.000271	0.00105	CcSEcCtD
Neostigmine—Asthenia—Orlistat—type 2 diabetes mellitus	0.000268	0.00104	CcSEcCtD
Neostigmine—Pruritus—Valsartan—type 2 diabetes mellitus	0.000267	0.00104	CcSEcCtD
Neostigmine—Dry mouth—Ramipril—type 2 diabetes mellitus	0.000267	0.00104	CcSEcCtD
Neostigmine—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	0.000265	0.00103	CcSEcCtD
Neostigmine—Pruritus—Orlistat—type 2 diabetes mellitus	0.000264	0.00103	CcSEcCtD
Neostigmine—Anaphylactic shock—Ramipril—type 2 diabetes mellitus	0.000262	0.00102	CcSEcCtD
Neostigmine—Vomiting—Gliclazide—type 2 diabetes mellitus	0.000261	0.00102	CcSEcCtD
Neostigmine—Rash—Gliclazide—type 2 diabetes mellitus	0.000259	0.00101	CcSEcCtD
Neostigmine—Dermatitis—Gliclazide—type 2 diabetes mellitus	0.000259	0.00101	CcSEcCtD
Neostigmine—Diarrhoea—Valsartan—type 2 diabetes mellitus	0.000258	0.001	CcSEcCtD
Neostigmine—Urticaria—Irbesartan—type 2 diabetes mellitus	0.000258	0.001	CcSEcCtD
Neostigmine—Shock—Ramipril—type 2 diabetes mellitus	0.000258	0.001	CcSEcCtD
Neostigmine—Headache—Gliclazide—type 2 diabetes mellitus	0.000257	0.001	CcSEcCtD
Neostigmine—Nervous system disorder—Ramipril—type 2 diabetes mellitus	0.000257	0.000999	CcSEcCtD
Neostigmine—Abdominal pain—Irbesartan—type 2 diabetes mellitus	0.000256	0.000998	CcSEcCtD
Neostigmine—Tachycardia—Ramipril—type 2 diabetes mellitus	0.000255	0.000994	CcSEcCtD
Neostigmine—Diarrhoea—Orlistat—type 2 diabetes mellitus	0.000255	0.000993	CcSEcCtD
Neostigmine—Skin disorder—Ramipril—type 2 diabetes mellitus	0.000254	0.000989	CcSEcCtD
Neostigmine—Hyperhidrosis—Ramipril—type 2 diabetes mellitus	0.000253	0.000984	CcSEcCtD
Neostigmine—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	0.00025	0.000971	CcSEcCtD
Neostigmine—Dizziness—Valsartan—type 2 diabetes mellitus	0.00025	0.000971	CcSEcCtD
Neostigmine—Dizziness—Orlistat—type 2 diabetes mellitus	0.000247	0.000959	CcSEcCtD
Neostigmine—Asthenia—Metformin—type 2 diabetes mellitus	0.000247	0.000959	CcSEcCtD
Neostigmine—Hypotension—Ramipril—type 2 diabetes mellitus	0.000245	0.000952	CcSEcCtD
Neostigmine—Nausea—Gliclazide—type 2 diabetes mellitus	0.000244	0.000949	CcSEcCtD
Neostigmine—Pruritus—Metformin—type 2 diabetes mellitus	0.000243	0.000946	CcSEcCtD
Neostigmine—Urticaria—Losartan—type 2 diabetes mellitus	0.000243	0.000943	CcSEcCtD
Neostigmine—Abdominal pain—Losartan—type 2 diabetes mellitus	0.000241	0.000939	CcSEcCtD
Neostigmine—Vomiting—Valsartan—type 2 diabetes mellitus	0.00024	0.000934	CcSEcCtD
Neostigmine—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	0.000239	0.00093	CcSEcCtD
Neostigmine—Musculoskeletal discomfort—Ramipril—type 2 diabetes mellitus	0.000238	0.000928	CcSEcCtD
Neostigmine—Rash—Valsartan—type 2 diabetes mellitus	0.000238	0.000926	CcSEcCtD
Neostigmine—Dermatitis—Valsartan—type 2 diabetes mellitus	0.000238	0.000925	CcSEcCtD
Neostigmine—Vomiting—Orlistat—type 2 diabetes mellitus	0.000237	0.000923	CcSEcCtD
Neostigmine—Insomnia—Ramipril—type 2 diabetes mellitus	0.000237	0.000921	CcSEcCtD
Neostigmine—Headache—Valsartan—type 2 diabetes mellitus	0.000236	0.00092	CcSEcCtD
Neostigmine—Diarrhoea—Metformin—type 2 diabetes mellitus	0.000235	0.000915	CcSEcCtD
Neostigmine—Rash—Orlistat—type 2 diabetes mellitus	0.000235	0.000915	CcSEcCtD
Neostigmine—Dermatitis—Orlistat—type 2 diabetes mellitus	0.000235	0.000914	CcSEcCtD
Neostigmine—Headache—Orlistat—type 2 diabetes mellitus	0.000234	0.000909	CcSEcCtD
Neostigmine—Dyspnoea—Ramipril—type 2 diabetes mellitus	0.000233	0.000908	CcSEcCtD
Neostigmine—Asthenia—Irbesartan—type 2 diabetes mellitus	0.000233	0.000905	CcSEcCtD
Neostigmine—Somnolence—Ramipril—type 2 diabetes mellitus	0.000233	0.000905	CcSEcCtD
Neostigmine—Pruritus—Irbesartan—type 2 diabetes mellitus	0.00023	0.000893	CcSEcCtD
Neostigmine—Dizziness—Metformin—type 2 diabetes mellitus	0.000227	0.000884	CcSEcCtD
Neostigmine—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	0.000226	0.000879	CcSEcCtD
Neostigmine—Hypersensitivity—Losartan—type 2 diabetes mellitus	0.000225	0.000875	CcSEcCtD
Neostigmine—Nausea—Valsartan—type 2 diabetes mellitus	0.000224	0.000872	CcSEcCtD
Neostigmine—Diarrhoea—Irbesartan—type 2 diabetes mellitus	0.000222	0.000863	CcSEcCtD
Neostigmine—Nausea—Orlistat—type 2 diabetes mellitus	0.000222	0.000862	CcSEcCtD
Neostigmine—Asthenia—Losartan—type 2 diabetes mellitus	0.000219	0.000852	CcSEcCtD
Neostigmine—Vomiting—Metformin—type 2 diabetes mellitus	0.000219	0.00085	CcSEcCtD
Neostigmine—Rash—Metformin—type 2 diabetes mellitus	0.000217	0.000843	CcSEcCtD
Neostigmine—Dermatitis—Metformin—type 2 diabetes mellitus	0.000217	0.000842	CcSEcCtD
Neostigmine—Pruritus—Losartan—type 2 diabetes mellitus	0.000216	0.00084	CcSEcCtD
Neostigmine—Headache—Metformin—type 2 diabetes mellitus	0.000215	0.000838	CcSEcCtD
Neostigmine—Dizziness—Irbesartan—type 2 diabetes mellitus	0.000215	0.000834	CcSEcCtD
Neostigmine—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	0.000214	0.000833	CcSEcCtD
Neostigmine—Diarrhoea—Losartan—type 2 diabetes mellitus	0.000209	0.000813	CcSEcCtD
Neostigmine—Urticaria—Ramipril—type 2 diabetes mellitus	0.000208	0.000809	CcSEcCtD
Neostigmine—Abdominal pain—Ramipril—type 2 diabetes mellitus	0.000207	0.000805	CcSEcCtD
Neostigmine—Vomiting—Irbesartan—type 2 diabetes mellitus	0.000206	0.000802	CcSEcCtD
Neostigmine—Rash—Irbesartan—type 2 diabetes mellitus	0.000205	0.000796	CcSEcCtD
Neostigmine—Dermatitis—Irbesartan—type 2 diabetes mellitus	0.000204	0.000795	CcSEcCtD
Neostigmine—Nausea—Metformin—type 2 diabetes mellitus	0.000204	0.000794	CcSEcCtD
Neostigmine—Headache—Irbesartan—type 2 diabetes mellitus	0.000203	0.000791	CcSEcCtD
Neostigmine—Dizziness—Losartan—type 2 diabetes mellitus	0.000202	0.000785	CcSEcCtD
Neostigmine—Vomiting—Losartan—type 2 diabetes mellitus	0.000194	0.000755	CcSEcCtD
Neostigmine—Hypersensitivity—Ramipril—type 2 diabetes mellitus	0.000193	0.00075	CcSEcCtD
Neostigmine—Nausea—Irbesartan—type 2 diabetes mellitus	0.000193	0.00075	CcSEcCtD
Neostigmine—Rash—Losartan—type 2 diabetes mellitus	0.000192	0.000749	CcSEcCtD
Neostigmine—Dermatitis—Losartan—type 2 diabetes mellitus	0.000192	0.000748	CcSEcCtD
Neostigmine—Headache—Losartan—type 2 diabetes mellitus	0.000191	0.000744	CcSEcCtD
Neostigmine—Asthenia—Ramipril—type 2 diabetes mellitus	0.000188	0.000731	CcSEcCtD
Neostigmine—Pruritus—Ramipril—type 2 diabetes mellitus	0.000185	0.00072	CcSEcCtD
Neostigmine—Nausea—Losartan—type 2 diabetes mellitus	0.000181	0.000705	CcSEcCtD
Neostigmine—Diarrhoea—Ramipril—type 2 diabetes mellitus	0.000179	0.000697	CcSEcCtD
Neostigmine—Dizziness—Ramipril—type 2 diabetes mellitus	0.000173	0.000673	CcSEcCtD
Neostigmine—Vomiting—Ramipril—type 2 diabetes mellitus	0.000166	0.000647	CcSEcCtD
Neostigmine—Rash—Ramipril—type 2 diabetes mellitus	0.000165	0.000642	CcSEcCtD
Neostigmine—Dermatitis—Ramipril—type 2 diabetes mellitus	0.000165	0.000641	CcSEcCtD
Neostigmine—Headache—Ramipril—type 2 diabetes mellitus	0.000164	0.000638	CcSEcCtD
Neostigmine—Nausea—Ramipril—type 2 diabetes mellitus	0.000155	0.000605	CcSEcCtD
Neostigmine—ACHE—Metabolism of lipids and lipoproteins—PPARA—type 2 diabetes mellitus	5.86e-05	0.000575	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—ALDOB—type 2 diabetes mellitus	5.85e-05	0.000573	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—BHMT—type 2 diabetes mellitus	5.85e-05	0.000573	CbGpPWpGaD
Neostigmine—ABCB1—Allograft Rejection—TGFB1—type 2 diabetes mellitus	5.82e-05	0.000571	CbGpPWpGaD
Neostigmine—BCHE—Metabolism of lipids and lipoproteins—GPX1—type 2 diabetes mellitus	5.78e-05	0.000567	CbGpPWpGaD
Neostigmine—ACHE—Metabolism of lipids and lipoproteins—AGT—type 2 diabetes mellitus	5.68e-05	0.000557	CbGpPWpGaD
Neostigmine—ABCB1—Transmembrane transport of small molecules—GCKR—type 2 diabetes mellitus	5.67e-05	0.000556	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—HK1—type 2 diabetes mellitus	5.63e-05	0.000552	CbGpPWpGaD
Neostigmine—BCHE—Metabolism of lipids and lipoproteins—CD36—type 2 diabetes mellitus	5.63e-05	0.000552	CbGpPWpGaD
Neostigmine—BCHE—Metabolism of proteins—GNB3—type 2 diabetes mellitus	5.62e-05	0.000551	CbGpPWpGaD
Neostigmine—ACHE—Metabolism of lipids and lipoproteins—APOE—type 2 diabetes mellitus	5.56e-05	0.000546	CbGpPWpGaD
Neostigmine—BCHE—Metabolism of proteins—IGF2—type 2 diabetes mellitus	5.52e-05	0.000541	CbGpPWpGaD
Neostigmine—ACHE—Metabolism of lipids and lipoproteins—APOA1—type 2 diabetes mellitus	5.5e-05	0.000539	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—GCKR—type 2 diabetes mellitus	5.44e-05	0.000533	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—KCNJ11—type 2 diabetes mellitus	5.44e-05	0.000533	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—HSD3B2—type 2 diabetes mellitus	5.44e-05	0.000533	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—LPA—type 2 diabetes mellitus	5.44e-05	0.000533	CbGpPWpGaD
Neostigmine—ABCB1—Allograft Rejection—TNF—type 2 diabetes mellitus	5.44e-05	0.000533	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—GLP1R—type 2 diabetes mellitus	5.44e-05	0.000533	CbGpPWpGaD
Neostigmine—ABCB1—Transmembrane transport of small molecules—ABCC2—type 2 diabetes mellitus	5.43e-05	0.000533	CbGpPWpGaD
Neostigmine—BCHE—Metabolism of lipids and lipoproteins—PPARA—type 2 diabetes mellitus	5.23e-05	0.000513	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—ALDOB—type 2 diabetes mellitus	5.22e-05	0.000511	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—AANAT—type 2 diabetes mellitus	5.11e-05	0.000501	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—PTGDS—type 2 diabetes mellitus	5.11e-05	0.000501	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—SLC2A2—type 2 diabetes mellitus	5.07e-05	0.000498	CbGpPWpGaD
Neostigmine—BCHE—Metabolism of lipids and lipoproteins—AGT—type 2 diabetes mellitus	5.07e-05	0.000497	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—MTR—type 2 diabetes mellitus	4.97e-05	0.000487	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—CPT1A—type 2 diabetes mellitus	4.97e-05	0.000487	CbGpPWpGaD
Neostigmine—ACHE—Metabolism of proteins—MMP1—type 2 diabetes mellitus	4.97e-05	0.000487	CbGpPWpGaD
Neostigmine—BCHE—Metabolism of lipids and lipoproteins—APOE—type 2 diabetes mellitus	4.96e-05	0.000487	CbGpPWpGaD
Neostigmine—BCHE—Metabolism of lipids and lipoproteins—APOA1—type 2 diabetes mellitus	4.91e-05	0.000481	CbGpPWpGaD
Neostigmine—ACHE—Metabolism of proteins—AGT—type 2 diabetes mellitus	4.91e-05	0.000481	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—type 2 diabetes mellitus	4.88e-05	0.000478	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—NAMPT—type 2 diabetes mellitus	4.88e-05	0.000478	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—GLP1R—type 2 diabetes mellitus	4.85e-05	0.000475	CbGpPWpGaD
Neostigmine—ACHE—Metabolism of lipids and lipoproteins—PPARG—type 2 diabetes mellitus	4.85e-05	0.000475	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—GCK—type 2 diabetes mellitus	4.84e-05	0.000475	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—HBA1—type 2 diabetes mellitus	4.84e-05	0.000475	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—LIPC—type 2 diabetes mellitus	4.84e-05	0.000475	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—CDO1—type 2 diabetes mellitus	4.84e-05	0.000475	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—GPD2—type 2 diabetes mellitus	4.84e-05	0.000475	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—CYP11A1—type 2 diabetes mellitus	4.81e-05	0.000472	CbGpPWpGaD
Neostigmine—ACHE—Metabolism of proteins—LEP—type 2 diabetes mellitus	4.81e-05	0.000471	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—type 2 diabetes mellitus	4.79e-05	0.00047	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—SLC9A1—type 2 diabetes mellitus	4.73e-05	0.000464	CbGpPWpGaD
Neostigmine—ABCB1—Transmembrane transport of small molecules—SLC2A2—type 2 diabetes mellitus	4.72e-05	0.000462	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—CETP—type 2 diabetes mellitus	4.67e-05	0.000458	CbGpPWpGaD
Neostigmine—ABCB1—HIF-1-alpha transcription factor network—AKT1—type 2 diabetes mellitus	4.67e-05	0.000458	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—AK1—type 2 diabetes mellitus	4.62e-05	0.000453	CbGpPWpGaD
Neostigmine—ACHE—Integrated Pancreatic Cancer Pathway—AKT1—type 2 diabetes mellitus	4.59e-05	0.00045	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—SLC2A2—type 2 diabetes mellitus	4.53e-05	0.000444	CbGpPWpGaD
Neostigmine—ABCB1—Transmembrane transport of small molecules—ATP2A2—type 2 diabetes mellitus	4.5e-05	0.000441	CbGpPWpGaD
Neostigmine—ABCB1—Transmembrane transport of small molecules—GCK—type 2 diabetes mellitus	4.5e-05	0.000441	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—CPT1A—type 2 diabetes mellitus	4.43e-05	0.000435	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—MTR—type 2 diabetes mellitus	4.43e-05	0.000435	CbGpPWpGaD
Neostigmine—BCHE—Metabolism of proteins—MMP1—type 2 diabetes mellitus	4.43e-05	0.000435	CbGpPWpGaD
Neostigmine—ABCB1—Transmembrane transport of small molecules—SLC9A1—type 2 diabetes mellitus	4.39e-05	0.000431	CbGpPWpGaD
Neostigmine—BCHE—Metabolism of proteins—AGT—type 2 diabetes mellitus	4.38e-05	0.000429	CbGpPWpGaD
Neostigmine—ABCB1—Transmembrane transport of small molecules—TRPC6—type 2 diabetes mellitus	4.37e-05	0.000428	CbGpPWpGaD
Neostigmine—ACHE—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	4.36e-05	0.000427	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—NAMPT—type 2 diabetes mellitus	4.35e-05	0.000426	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—PSMD6—type 2 diabetes mellitus	4.35e-05	0.000426	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—SNAP25—type 2 diabetes mellitus	4.35e-05	0.000426	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—SREBF1—type 2 diabetes mellitus	4.35e-05	0.000426	CbGpPWpGaD
Neostigmine—ABCB1—Transmembrane transport of small molecules—CETP—type 2 diabetes mellitus	4.34e-05	0.000426	CbGpPWpGaD
Neostigmine—BCHE—Metabolism of lipids and lipoproteins—PPARG—type 2 diabetes mellitus	4.32e-05	0.000424	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—LIPC—type 2 diabetes mellitus	4.32e-05	0.000424	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—HBA1—type 2 diabetes mellitus	4.32e-05	0.000424	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—GCK—type 2 diabetes mellitus	4.32e-05	0.000424	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—CYP11A1—type 2 diabetes mellitus	4.3e-05	0.000421	CbGpPWpGaD
Neostigmine—BCHE—Metabolism of proteins—LEP—type 2 diabetes mellitus	4.29e-05	0.000421	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—CTGF—type 2 diabetes mellitus	4.27e-05	0.000418	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—SLC5A4—type 2 diabetes mellitus	4.27e-05	0.000418	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—MAT1A—type 2 diabetes mellitus	4.27e-05	0.000418	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—HMGCR—type 2 diabetes mellitus	4.23e-05	0.000414	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—SLC9A1—type 2 diabetes mellitus	4.22e-05	0.000414	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—type 2 diabetes mellitus	4.18e-05	0.00041	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—CETP—type 2 diabetes mellitus	4.17e-05	0.000409	CbGpPWpGaD
Neostigmine—ACHE—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	4.17e-05	0.000409	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—ADRA2A—type 2 diabetes mellitus	4.14e-05	0.000406	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—ND1—type 2 diabetes mellitus	4.12e-05	0.000404	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—G6PC—type 2 diabetes mellitus	4.12e-05	0.000404	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—PPP1R3C—type 2 diabetes mellitus	4.12e-05	0.000404	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—ENPP1—type 2 diabetes mellitus	4.12e-05	0.000404	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—HBA2—type 2 diabetes mellitus	4.12e-05	0.000404	CbGpPWpGaD
Neostigmine—ACHE—Metabolism of proteins—INS—type 2 diabetes mellitus	4.11e-05	0.000403	CbGpPWpGaD
Neostigmine—ACHE—Metabolism of proteins—CCL2—type 2 diabetes mellitus	4.04e-05	0.000396	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—GCGR—type 2 diabetes mellitus	3.99e-05	0.000391	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—type 2 diabetes mellitus	3.97e-05	0.00039	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—CYP2E1—type 2 diabetes mellitus	3.97e-05	0.00039	CbGpPWpGaD
Neostigmine—ACHE—Metabolism of proteins—IGF1—type 2 diabetes mellitus	3.97e-05	0.00039	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—SLC2A1—type 2 diabetes mellitus	3.93e-05	0.000385	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—CYP1A2—type 2 diabetes mellitus	3.93e-05	0.000385	CbGpPWpGaD
Neostigmine—BCHE—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	3.89e-05	0.000381	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—PSMD6—type 2 diabetes mellitus	3.88e-05	0.00038	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—SNAP25—type 2 diabetes mellitus	3.88e-05	0.00038	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—SREBF1—type 2 diabetes mellitus	3.88e-05	0.00038	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—CYP3A4—type 2 diabetes mellitus	3.83e-05	0.000376	CbGpPWpGaD
Neostigmine—ABCB1—Transmembrane transport of small molecules—PLAT—type 2 diabetes mellitus	3.83e-05	0.000375	CbGpPWpGaD
Neostigmine—ACHE—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	3.81e-05	0.000374	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—CTGF—type 2 diabetes mellitus	3.81e-05	0.000373	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—HMGCR—type 2 diabetes mellitus	3.77e-05	0.00037	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—GCG—type 2 diabetes mellitus	3.77e-05	0.000369	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—SLC2A4—type 2 diabetes mellitus	3.77e-05	0.000369	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—OXCT1—type 2 diabetes mellitus	3.77e-05	0.000369	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—CYTB—type 2 diabetes mellitus	3.77e-05	0.000369	CbGpPWpGaD
Neostigmine—BCHE—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	3.72e-05	0.000365	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—ADRA2A—type 2 diabetes mellitus	3.69e-05	0.000362	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—type 2 diabetes mellitus	3.69e-05	0.000362	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—SRD5A1—type 2 diabetes mellitus	3.67e-05	0.00036	CbGpPWpGaD
Neostigmine—BCHE—Metabolism of proteins—INS—type 2 diabetes mellitus	3.66e-05	0.000359	CbGpPWpGaD
Neostigmine—ABCB1—Transmembrane transport of small molecules—SLC2A1—type 2 diabetes mellitus	3.65e-05	0.000358	CbGpPWpGaD
Neostigmine—BCHE—Metabolism of proteins—CCL2—type 2 diabetes mellitus	3.61e-05	0.000354	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—CYP2E1—type 2 diabetes mellitus	3.55e-05	0.000348	CbGpPWpGaD
Neostigmine—BCHE—Metabolism of proteins—IGF1—type 2 diabetes mellitus	3.54e-05	0.000348	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—SLC2A1—type 2 diabetes mellitus	3.51e-05	0.000344	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—CYP1A2—type 2 diabetes mellitus	3.51e-05	0.000344	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—HSD17B3—type 2 diabetes mellitus	3.5e-05	0.000343	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—STAR—type 2 diabetes mellitus	3.5e-05	0.000343	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—ACACA—type 2 diabetes mellitus	3.5e-05	0.000343	CbGpPWpGaD
Neostigmine—ABCB1—Transmembrane transport of small molecules—SLC2A4—type 2 diabetes mellitus	3.5e-05	0.000343	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—type 2 diabetes mellitus	3.45e-05	0.000338	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—CYP3A4—type 2 diabetes mellitus	3.42e-05	0.000335	CbGpPWpGaD
Neostigmine—BCHE—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	3.4e-05	0.000334	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—GCG—type 2 diabetes mellitus	3.36e-05	0.00033	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—SLC2A4—type 2 diabetes mellitus	3.36e-05	0.00033	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—ABCC8—type 2 diabetes mellitus	3.36e-05	0.000329	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—CBS—type 2 diabetes mellitus	3.36e-05	0.000329	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—GNB3—type 2 diabetes mellitus	3.25e-05	0.000318	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—PPARGC1A—type 2 diabetes mellitus	3.25e-05	0.000318	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—HMOX1—type 2 diabetes mellitus	3.23e-05	0.000317	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—SLC5A2—type 2 diabetes mellitus	3.23e-05	0.000317	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—COX2—type 2 diabetes mellitus	3.23e-05	0.000317	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—type 2 diabetes mellitus	3.21e-05	0.000315	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—CAT—type 2 diabetes mellitus	3.19e-05	0.000313	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—NCOA6—type 2 diabetes mellitus	3.18e-05	0.000311	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—type 2 diabetes mellitus	3.13e-05	0.000307	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—UCP3—type 2 diabetes mellitus	3.12e-05	0.000306	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—UCP2—type 2 diabetes mellitus	3.12e-05	0.000306	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—HSD11B1—type 2 diabetes mellitus	3.12e-05	0.000306	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—APOB—type 2 diabetes mellitus	3.1e-05	0.000304	CbGpPWpGaD
Neostigmine—ABCB1—Transmembrane transport of small molecules—GNB3—type 2 diabetes mellitus	3.02e-05	0.000296	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—GSTM1—type 2 diabetes mellitus	3.01e-05	0.000295	CbGpPWpGaD
Neostigmine—ABCB1—Transmembrane transport of small molecules—HMOX1—type 2 diabetes mellitus	3e-05	0.000295	CbGpPWpGaD
Neostigmine—ABCB1—Transmembrane transport of small molecules—AVP—type 2 diabetes mellitus	2.98e-05	0.000292	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—LPL—type 2 diabetes mellitus	2.96e-05	0.00029	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—PCK1—type 2 diabetes mellitus	2.94e-05	0.000288	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—GNB3—type 2 diabetes mellitus	2.9e-05	0.000284	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—PPARGC1A—type 2 diabetes mellitus	2.9e-05	0.000284	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—ADCY5—type 2 diabetes mellitus	2.89e-05	0.000284	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—GPX1—type 2 diabetes mellitus	2.88e-05	0.000283	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—HMOX1—type 2 diabetes mellitus	2.88e-05	0.000283	CbGpPWpGaD
Neostigmine—ABCB1—Transmembrane transport of small molecules—APOB—type 2 diabetes mellitus	2.88e-05	0.000282	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—type 2 diabetes mellitus	2.87e-05	0.000282	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—CAT—type 2 diabetes mellitus	2.85e-05	0.000279	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—type 2 diabetes mellitus	2.82e-05	0.000276	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—CD36—type 2 diabetes mellitus	2.81e-05	0.000275	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—PPP2CA—type 2 diabetes mellitus	2.77e-05	0.000272	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—APOB—type 2 diabetes mellitus	2.76e-05	0.000271	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—HK1—type 2 diabetes mellitus	2.75e-05	0.000269	CbGpPWpGaD
Neostigmine—ABCB1—Transmembrane transport of small molecules—ADCY5—type 2 diabetes mellitus	2.69e-05	0.000264	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—GSTM1—type 2 diabetes mellitus	2.69e-05	0.000263	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—type 2 diabetes mellitus	2.68e-05	0.000263	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—MTHFR—type 2 diabetes mellitus	2.66e-05	0.000261	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—GCKR—type 2 diabetes mellitus	2.65e-05	0.00026	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—KCNJ11—type 2 diabetes mellitus	2.65e-05	0.00026	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—HSD3B2—type 2 diabetes mellitus	2.65e-05	0.00026	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—LPA—type 2 diabetes mellitus	2.65e-05	0.00026	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—LPL—type 2 diabetes mellitus	2.64e-05	0.000259	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—PPARA—type 2 diabetes mellitus	2.61e-05	0.000256	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—ADCY5—type 2 diabetes mellitus	2.58e-05	0.000253	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—GPX1—type 2 diabetes mellitus	2.57e-05	0.000252	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—ALDOB—type 2 diabetes mellitus	2.54e-05	0.00025	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—AGT—type 2 diabetes mellitus	2.53e-05	0.000248	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—CD36—type 2 diabetes mellitus	2.51e-05	0.000246	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—CALM1—type 2 diabetes mellitus	2.49e-05	0.000244	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—APOE—type 2 diabetes mellitus	2.48e-05	0.000243	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—PPP2CA—type 2 diabetes mellitus	2.47e-05	0.000243	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—APOA1—type 2 diabetes mellitus	2.45e-05	0.00024	CbGpPWpGaD
Neostigmine—ABCB1—Transmembrane transport of small molecules—PPARA—type 2 diabetes mellitus	2.43e-05	0.000238	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—MTHFR—type 2 diabetes mellitus	2.37e-05	0.000233	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—GLP1R—type 2 diabetes mellitus	2.37e-05	0.000232	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—PPARA—type 2 diabetes mellitus	2.33e-05	0.000228	CbGpPWpGaD
Neostigmine—ABCB1—Transmembrane transport of small molecules—APOA1—type 2 diabetes mellitus	2.28e-05	0.000223	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—AGT—type 2 diabetes mellitus	2.26e-05	0.000221	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—CALM1—type 2 diabetes mellitus	2.22e-05	0.000218	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—APOE—type 2 diabetes mellitus	2.21e-05	0.000217	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—SLC2A2—type 2 diabetes mellitus	2.21e-05	0.000217	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—APOA1—type 2 diabetes mellitus	2.19e-05	0.000214	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—CPT1A—type 2 diabetes mellitus	2.16e-05	0.000212	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—MTR—type 2 diabetes mellitus	2.16e-05	0.000212	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—PPARG—type 2 diabetes mellitus	2.16e-05	0.000212	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—NAMPT—type 2 diabetes mellitus	2.12e-05	0.000208	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—INS—type 2 diabetes mellitus	2.12e-05	0.000208	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—HBA1—type 2 diabetes mellitus	2.11e-05	0.000207	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—LIPC—type 2 diabetes mellitus	2.11e-05	0.000207	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—GCK—type 2 diabetes mellitus	2.11e-05	0.000207	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—CYP11A1—type 2 diabetes mellitus	2.1e-05	0.000205	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—SLC9A1—type 2 diabetes mellitus	2.06e-05	0.000202	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—CETP—type 2 diabetes mellitus	2.03e-05	0.000199	CbGpPWpGaD
Neostigmine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—type 2 diabetes mellitus	2e-05	0.000196	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—ALB—type 2 diabetes mellitus	1.94e-05	0.00019	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—PPARG—type 2 diabetes mellitus	1.93e-05	0.000189	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—PSMD6—type 2 diabetes mellitus	1.89e-05	0.000185	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—SNAP25—type 2 diabetes mellitus	1.89e-05	0.000185	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—SREBF1—type 2 diabetes mellitus	1.89e-05	0.000185	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—INS—type 2 diabetes mellitus	1.89e-05	0.000185	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—PIK3R1—type 2 diabetes mellitus	1.86e-05	0.000182	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—NOS3—type 2 diabetes mellitus	1.86e-05	0.000182	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—CTGF—type 2 diabetes mellitus	1.86e-05	0.000182	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—HMGCR—type 2 diabetes mellitus	1.84e-05	0.00018	CbGpPWpGaD
Neostigmine—ABCB1—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	1.8e-05	0.000177	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—ADRA2A—type 2 diabetes mellitus	1.8e-05	0.000177	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—ALB—type 2 diabetes mellitus	1.73e-05	0.00017	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—CYP2E1—type 2 diabetes mellitus	1.73e-05	0.00017	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—SLC2A1—type 2 diabetes mellitus	1.71e-05	0.000168	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—CYP1A2—type 2 diabetes mellitus	1.71e-05	0.000168	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—PTGS2—type 2 diabetes mellitus	1.7e-05	0.000166	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—CYP3A4—type 2 diabetes mellitus	1.67e-05	0.000164	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—PIK3R1—type 2 diabetes mellitus	1.66e-05	0.000162	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—NOS3—type 2 diabetes mellitus	1.66e-05	0.000162	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—GCG—type 2 diabetes mellitus	1.64e-05	0.000161	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—SLC2A4—type 2 diabetes mellitus	1.64e-05	0.000161	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—PTGS2—type 2 diabetes mellitus	1.51e-05	0.000149	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—PPARGC1A—type 2 diabetes mellitus	1.41e-05	0.000139	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—GNB3—type 2 diabetes mellitus	1.41e-05	0.000139	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—HMOX1—type 2 diabetes mellitus	1.41e-05	0.000138	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—CAT—type 2 diabetes mellitus	1.39e-05	0.000136	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—APOB—type 2 diabetes mellitus	1.35e-05	0.000132	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—GSTM1—type 2 diabetes mellitus	1.31e-05	0.000129	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—LPL—type 2 diabetes mellitus	1.29e-05	0.000126	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—ADCY5—type 2 diabetes mellitus	1.26e-05	0.000124	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—GPX1—type 2 diabetes mellitus	1.26e-05	0.000123	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—CD36—type 2 diabetes mellitus	1.22e-05	0.00012	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—PPP2CA—type 2 diabetes mellitus	1.21e-05	0.000118	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—MTHFR—type 2 diabetes mellitus	1.16e-05	0.000114	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—PPARA—type 2 diabetes mellitus	1.14e-05	0.000111	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—AGT—type 2 diabetes mellitus	1.1e-05	0.000108	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—CALM1—type 2 diabetes mellitus	1.08e-05	0.000106	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—APOE—type 2 diabetes mellitus	1.08e-05	0.000106	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—APOA1—type 2 diabetes mellitus	1.07e-05	0.000105	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—PPARG—type 2 diabetes mellitus	9.4e-06	9.21e-05	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—INS—type 2 diabetes mellitus	9.21e-06	9.04e-05	CbGpPWpGaD
Neostigmine—ACHE—Metabolism—AKT1—type 2 diabetes mellitus	8.53e-06	8.37e-05	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—ALB—type 2 diabetes mellitus	8.45e-06	8.28e-05	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—PIK3R1—type 2 diabetes mellitus	8.08e-06	7.92e-05	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—NOS3—type 2 diabetes mellitus	8.08e-06	7.92e-05	CbGpPWpGaD
Neostigmine—BCHE—Metabolism—AKT1—type 2 diabetes mellitus	7.61e-06	7.47e-05	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—PTGS2—type 2 diabetes mellitus	7.39e-06	7.25e-05	CbGpPWpGaD
Neostigmine—ABCB1—Metabolism—AKT1—type 2 diabetes mellitus	3.71e-06	3.64e-05	CbGpPWpGaD
